News & Updates

Prompt DOAC therapy after stroke safe for AF patients

11 Nov 2024 by

Initiating direct oral anticoagulants (DOACs) within 4 days after an ischaemic stroke in patients with atrial fibrillation (AF) is safe and yields similar outcomes as delayed initiation, as shown in the phase 4 OPTIMAS trial.

Prompt DOAC therapy after stroke safe for AF patients

11 Nov 2024

Morning tiredness, insomnia tied to BP elevation among postmenopausal women

10 Nov 2024

Postmenopausal women with elevated levels of evening blood pressure (BP) appear to experience morning tiredness and insomnia, as reported in a study.

Morning tiredness, insomnia tied to BP elevation among postmenopausal women

10 Nov 2024

Cumulative pulse pressure load tied to all-cause death in older adults

08 Nov 2024 by

Long-term exposure to elevated cumulative pulse pressure (cPP) potentially increases the risk of all-cause deaths, while prolonged exposure to elevated cumulative systolic blood pressure (cSBP) contributes to a higher risk of cardiovascular death, suggests a study.

Cumulative pulse pressure load tied to all-cause death in older adults

08 Nov 2024

CVD risk remain high despite successful treatment for depression

08 Nov 2024

A recent study suggests that successful treatment of depression alone is not enough to protect patients against the associated risk of cardiovascular disease (CVD).

CVD risk remain high despite successful treatment for depression

08 Nov 2024

Hyperuricaemia linked to short-term readmission, mortality risk in HF

06 Nov 2024

For patients with heart failure (HF), hyperuricaemia is a risk factor for an increase in the risk of short-term hospital readmission and mortality, as reported in a retrospective study.

Hyperuricaemia linked to short-term readmission, mortality risk in HF

06 Nov 2024

Mitral TEER clips hold benefits at 1 year in patients with atrial SMR

06 Nov 2024 by

An analysis of the EXPANDed patient-level pooled cohort presented at HFSA 2024 demonstrates clinical benefits in patients with atrial SMR at 1 year following a mitral TEER procedure using newer-generation clip devices. These included a significant reduction in MR and substantial improvements in PROs

Mitral TEER clips hold benefits at 1 year in patients with atrial SMR

06 Nov 2024

Tailored peritoneal dialysis training program cuts infection, dropout rates

05 Nov 2024 by

A Singapore hospital has pioneered a tailored peritoneal dialysis (PD) training program that has yielded a significant reduction in PD-related infections and dropouts among patients with end-stage kidney disease (ESKD).

Tailored peritoneal dialysis training program cuts infection, dropout rates

05 Nov 2024

Are SGLT2 inhibitors cardioprotective in wild-type ATTR-CM patients?

05 Nov 2024 by

The use of sodium glucose cotransporter-2 (SGLT2) inhibitors nearly halves the risk of all-cause mortality at 3 years in patients with wild-type transthyretin amyloid cardiomyopathy (ATTR-CM) and type 2 diabetes (T2D), findings from an observational study suggest.

Are SGLT2 inhibitors cardioprotective in wild-type ATTR-CM patients?

05 Nov 2024

More than 90 percent of HK’s population has CKM syndrome

05 Nov 2024 by

The proportion of Hong Kong’s population with cardiovascular-kidney-metabolic (CKM) syndrome has increased from 87.8 percent 20 years ago to 90.8 percent in 2024, an ongoing population-based, cross-sectional study of cardiovascular (CV) risk factors and disease prevalence in Hong Kong Chinese (N-CRISPS) has found.

More than 90 percent of HK’s population has CKM syndrome

05 Nov 2024

The role of treat-to-target in inflammatory arthritis: Addressing cardiovascular risk and evaluating the benefit-risk profile of upadacitinib

04 Nov 2024

In this article, Professor Tam discusses her management approach to optimising outcomes in patients with inflammatory arthritis. She explores the role of the treat-to-target approach, emphasizes the importance of early disease control in reducing cardiovascular risk and evaluates the benefit-risk analysis of upadacitinib.

The role of treat-to-target in inflammatory arthritis: Addressing cardiovascular risk and evaluating the benefit-risk profile of upadacitinib

04 Nov 2024

News & Updates

Filter by Specialty:

Specialty:

Prompt DOAC therapy after stroke safe for AF patients

Prompt DOAC therapy after stroke safe for AF patients

Morning tiredness, insomnia tied to BP elevation among postmenopausal women

Morning tiredness, insomnia tied to BP elevation among postmenopausal women

Cumulative pulse pressure load tied to all-cause death in older adults

Cumulative pulse pressure load tied to all-cause death in older adults

CVD risk remain high despite successful treatment for depression

CVD risk remain high despite successful treatment for depression

Hyperuricaemia linked to short-term readmission, mortality risk in HF

Hyperuricaemia linked to short-term readmission, mortality risk in HF

Mitral TEER clips hold benefits at 1 year in patients with atrial SMR

Mitral TEER clips hold benefits at 1 year in patients with atrial SMR

Tailored peritoneal dialysis training program cuts infection, dropout rates

Tailored peritoneal dialysis training program cuts infection, dropout rates

Are SGLT2 inhibitors cardioprotective in wild-type ATTR-CM patients?

Are SGLT2 inhibitors cardioprotective in wild-type ATTR-CM patients?

More than 90 percent of HK’s population has CKM syndrome

More than 90 percent of HK’s population has CKM syndrome

The role of treat-to-target in inflammatory arthritis: Addressing cardiovascular risk and evaluating the benefit-risk profile of upadacitinib

The role of treat-to-target in inflammatory arthritis: Addressing cardiovascular risk and evaluating the benefit-risk profile of upadacitinib